Immunovia publishes link to Webinar No. 3 on IMMray PanCan-d: Verification Study and Clinical Use LUND, Sweden, Dec. 14, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") today published the link to the company's third webinar in a series on IMMray PanCan-d, Immunovia's test for early detection of pancreatic cancer. The webinar will cover the IMMray PanCan-d verification study results and its clinical use, including feedback from experts in pancreatic cancer and pancreatic diseases. Event Details: Date and Time: December 17, 2020 at 15:00 CET Moderator for the webinar: CEO Patrik Dahlen Presenters: Thomas King, MD, PhD; Linda Mellby, PhD, VP R&D; and Laura Chirica, CCO, PhD, Immunovia